-transparent.png){kind=logo}
Of six patients with rheumatoid arthritis (RA) treated with human recombinant interferon gamma for two to eight months, three developed antinuclear antibodies (ANAs). This was accompanied by a simultaneous clinical exacerbation of the disease activity. In this study both anti-inflammatory and immunostimulatory effects of human recombinant interferon gamma in patients with RA were observed.
Related Publications
M Seitz, and
M Franke, and
H Kirchner
October 1970,
Polski tygodnik lekarski (Warsaw, Poland : 1960),
M Seitz, and
M Franke, and
H Kirchner
January 1989,
Zeitschrift fur Rheumatologie,
M Seitz, and
M Franke, and
H Kirchner
December 2004,
Arthritis and rheumatism,
M Seitz, and
M Franke, and
H Kirchner
April 1988,
The Journal of rheumatology,
M Seitz, and
M Franke, and
H Kirchner
April 2003,
Arthritis and rheumatism,
M Seitz, and
M Franke, and
H Kirchner
January 1973,
Sbornik vedeckych praci Lekarske fakulty Karlovy univerzity v Hradci Kralove. Supplementum,
M Seitz, and
M Franke, and
H Kirchner
September 1992,
Annals of the rheumatic diseases,
M Seitz, and
M Franke, and
H Kirchner
March 1970,
Connecticut medicine,
M Seitz, and
M Franke, and
H Kirchner
December 1987,
Journal of biological response modifiers,
M Seitz, and
M Franke, and
H Kirchner
August 1985,
Vnitrni lekarstvi,
